Higher infused lymphocyte dose predicts higher lymphocyte recovery, which in turn, predicts superior overall survival following autologous hematopoietic stem cell transplantation for multiple myeloma.

Source:http://linkedlifedata.com/resource/pubmed/id/18158968

Download in:

View as

General Info

PMID
18158968